The relationship between Multidrug Resistance Protein 1(rs1045642) and Cholesterol 24-hydroxylase (rs754203) genes polymorphism with type 2 diabetes mellitus

References

• World Health Organization. Global report on diabetes. 2016. Geneva. Available from: http://www.who.int/diabetes/global-report/en/
   Google Scholar
• International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels; 2015. Available from: http://www.idf.org/idf-diabetes-atlas-seventh-edition.
   Google Scholar
• McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010;363:2339–2350.
   PubMed Web of Science ®Google Scholar
• Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981–990.10.1038/ng.2383
   PubMed Web of Science ®Google Scholar
• Burchenal JH, Robinson E. The induction of resistance to 4-amino-N10-methylpteroylglutamic acid in a strain of transmitted mouse leukemia. Science. 1950;111:116–117.10.1126/science.111.2875.116
   PubMed Web of Science ®Google Scholar
• Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA. 2000;97:3473–3478.10.1073/pnas.97.7.3473
   PubMed Web of Science ®Google Scholar
• Kaya P, Gündüz U, Arpaci F, et al. Identification of polymorphisms on the MDR1 gene among Turkish population and their effects on multidrug resistance in acute leukemia patients. Am J Haematol. 2005;80:26–34.10.1002/(ISSN)1096-8652
   PubMed Web of Science ®Google Scholar
• Fellay J, Marzolini C, Meaden ER, et al. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. The Lancet. 2002;359:30–36.10.1016/S0140-6736(02)07276-8
   PubMed Web of Science ®Google Scholar
• Hitzl M, Drescher S, van der Kuip H, et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56C natural killer cells. Pharmacogenetics. 2001;11:293–298.10.1097/00008571-200106000-00003
   PubMedGoogle Scholar
• Yamada Y, Matsuo H, Watanabe S, et al. Association of a polymorphism of CYP3A4 with type 2 diabetes mellitus. Int J Mol Med. 2007;20:703–707.
   PubMed Web of Science ®Google Scholar
• Wang CP, Hung WC, Yu TH, et al. Genetic variation in the G-50T polymorphism of the cytochrome P450 epoxygenase CYP2J2 gene and the risk of younger onset type 2 diabetes among Chinese population: potential interaction with body mass index and family history. Exp Clin Endocrinol Diabetes. 2010;118:346–352.10.1055/s-0029-1243604
   PubMed Web of Science ®Google Scholar
• Juhász A, Rimanóczy A, Boda K, et al. CYP46 T/C polymorphism is not associated with Alzheimer’s dementia in a population from Hungary. Neurochem Res. 2005;30:943–948.10.1007/s11064-005-5979-4
   PubMed Web of Science ®Google Scholar
• Chu LW, Chen YQ, Cheung BM, et al. Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer’s disease in Chinese patients. Dement Geriatr Cogn Disord. 2006;22:399–404.
   PubMed Web of Science ®Google Scholar
• Tedde A, Rotondi M, Cellini E, et al. Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer’s disease. Neurobiol Aging. 2006;27:773.e1–773.e3.
   Web of Science ®Google Scholar
• Janson J, Laedtke T, Parisi JE, et al. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes. 2004;53:474–481.10.2337/diabetes.53.2.474
   PubMed Web of Science ®Google Scholar
• Karatoprak O, Karaali ZE, İncekara K, et al. The role of mdr1 gene polymorphisms in type 2 diabetes mellitus. Turk J Biochem. 2013;38:186–192.10.5505/tjb.2013.41736
   Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:S62–S69.
   PubMed Web of Science ®Google Scholar
• Li YH, Wang YH, Li Y, et al. MDR1 gene polymorphisms and clinical relevance. Acta Genet Sin. 2006;33:93–104.10.1016/S0379-4172(06)60027-9
   Google Scholar
• Li Z, Kai L, Wusheng L, et al. Association between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibility. Tumor Biology. 2013;34:1949–1957.
   PubMed Web of Science ®Google Scholar
• Lee CG, Tang K, Cheung YB, et al. MDR1, the blood-brain barrier transporter, is associated with Parkinson’s disease in ethnic Chinese. J Med Genet. 2004;41:e60.10.1136/jmg.2003.013003
   PubMed Web of Science ®Google Scholar
• Kedmi M, Maayan S, Cohen SB, et al. MDR1 and CYP3A4 Polymorphisms are associated with HIV seropositivity in Israeli patients but do not influence the course of HIV disease. AIDS Patient Care and STDS. 2007;21:653–658.10.1089/apc.2006.0148
   PubMed Web of Science ®Google Scholar
• Kivistö KT, Niemi M, Schaeffeler E, et al. CYP3A5 genotype is associated with diagnosis of hypertension in elderly patients: data from the DEBATE Study. Am J Pharmacogenomics. 2005;5:191–195.10.2165/00129785-200505030-00005
   PubMedGoogle Scholar
• Pawlik A, Wrzesniewska J, Fiedorowicz-Fabrycy I, et al. The MDR1 3435 polymorphism in patients with rheumatoid arthritis. Int J Clin Pharmacol Ther. 2004;42:496–503.10.5414/CPP42496
   PubMed Web of Science ®Google Scholar
• Wang D, Johnson AD, Papp AC, et al. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics. 2005;15:693–704.10.1097/01.fpc.0000178311.02878.83
   PubMed Web of Science ®Google Scholar
• Pawlik A, Baskiewicz-Masiuk M, Machalinski B, et al. Involvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. Eur J Pharmacol. 2005;528:27–36.10.1016/j.ejphar.2005.10.068
   PubMed Web of Science ®Google Scholar
• Balram C, Sharma A, Sivathasan C, et al. Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic–genotypic correlates. Br J Clin Pharmacol. 2003;56:78–83.10.1046/j.1365-2125.2003.01820.x
   PubMed Web of Science ®Google Scholar
• Rao DN, Anuradha C, Vishnupriya S, et al. Association of an MDR gene (C3435T) polymorphism with acute leukemia in India. Asian Pac J Cancer Prev. 2010;11:1063–1066.
   PubMed Web of Science ®Google Scholar
• Besseling J, Kastelein JJP, Defesche JC, et al. Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus. JAMA. 2015;313:1029–1036.10.1001/jama.2015.1206
   PubMed Web of Science ®Google Scholar